HRC Ledger
Opportunity

AXION BIOSYSTEMS MAESTRO PRO MICROELECTRODE ARRAY (MEA) SYSTEM – BRAND NAME OR EQUAL

Response due

September 16, 2026

Agency
Food and Drug Administration
Estimated value
Not stated
This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with Federal Acquisition Regulation (FAR) Part 12, as implemented through the Revolutionary FAR Overhaul (RFO) model deviation and applicable Department of Health and Human Services (HHS) class deviations. This announcement constitutes solicitation. Quotations are being requested, and a separate written solicitation will not be issued. Solicitation No. CBER-2026-135659 is issued as a Request for Quotation (RFQ) for the purchase of an Axion BioSystems Maestro Pro Microelectrode Array (MEA) System, brand name or equal, together with the required software, consumables, installation, training, warranty, and an option for preventive maintenance. This acquisition is not set aside for small business concerns and is being competed on an unrestricted basis. The Government intends to issue a Firm-Fixed-Price purchase order using simplified procedures for commercial products and commercial services under RFO FAR Part 12. Please refer to the Combined Synopsis-Solicitation Maestro Pro Microelectrode Array System Document and all the attachments for specfic details about the requirement

Key dates

Posted
September 9, 2026
Response due
September 16, 2026

Organization

Food and Drug Administration

Buying history

  • Records7 total
  • Opportunities / awards0 / 0
  • ActiveAugust 14, 2026 – September 10, 2026

What they buy

  • Clinical (7)

Set-asides used

  • Small Business Set Aside - Total (4)
  • No Set aside used (3)
View source document →

Source link on sam.gov.

Source record

Buyer type
Federal
Jurisdiction
Federal (US)
Category
Clinical
Set-aside
No Set aside used
NAICS
334516
PSC
6640